| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mucin-1 | 33 | 2020 | 544 | 2.170 |
Why?
|
| Nanoparticles | 9 | 2023 | 1905 | 0.720 |
Why?
|
| Carcinoma, Ehrlich Tumor | 4 | 2015 | 24 | 0.520 |
Why?
|
| Proto-Oncogene Proteins c-abl | 6 | 2008 | 146 | 0.430 |
Why?
|
| Oligopeptides | 6 | 2018 | 1178 | 0.380 |
Why?
|
| Oncogene Proteins | 4 | 2018 | 749 | 0.310 |
Why?
|
| Apoptosis | 20 | 2021 | 9728 | 0.280 |
Why?
|
| Cell Line, Tumor | 29 | 2023 | 16687 | 0.270 |
Why?
|
| Coumarins | 2 | 2004 | 119 | 0.260 |
Why?
|
| Antineoplastic Agents | 11 | 2023 | 13668 | 0.260 |
Why?
|
| fms-Like Tyrosine Kinase 3 | 3 | 2013 | 491 | 0.240 |
Why?
|
| Nanocapsules | 2 | 2015 | 91 | 0.230 |
Why?
|
| Peptides | 8 | 2017 | 4407 | 0.220 |
Why?
|
| Isocoumarins | 4 | 2006 | 19 | 0.210 |
Why?
|
| MAP Kinase Kinase 4 | 2 | 2003 | 148 | 0.190 |
Why?
|
| Cell Survival | 10 | 2018 | 5881 | 0.190 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 5 | 2021 | 1434 | 0.190 |
Why?
|
| MAP Kinase Kinase Kinase 1 | 1 | 2000 | 58 | 0.190 |
Why?
|
| Cell-Penetrating Peptides | 1 | 2020 | 44 | 0.180 |
Why?
|
| Neoplasms | 8 | 2023 | 21672 | 0.180 |
Why?
|
| Proto-Oncogene Proteins c-akt | 5 | 2022 | 2503 | 0.180 |
Why?
|
| Transcription Factor RelA | 3 | 2016 | 275 | 0.180 |
Why?
|
| Phosphatidylinositol 3-Kinases | 5 | 2022 | 2938 | 0.170 |
Why?
|
| DNA Damage | 4 | 2006 | 2432 | 0.160 |
Why?
|
| Caspases | 5 | 2011 | 928 | 0.160 |
Why?
|
| Oleanolic Acid | 2 | 2010 | 43 | 0.160 |
Why?
|
| Histone Deacetylase Inhibitors | 2 | 2022 | 789 | 0.160 |
Why?
|
| Quinazolinones | 1 | 2020 | 221 | 0.160 |
Why?
|
| Paclitaxel | 4 | 2018 | 1707 | 0.160 |
Why?
|
| Polymers | 3 | 2022 | 1620 | 0.160 |
Why?
|
| Mice, Inbred BALB C | 10 | 2020 | 6386 | 0.150 |
Why?
|
| Reactive Oxygen Species | 8 | 2017 | 2078 | 0.150 |
Why?
|
| Antineoplastic Agents, Phytogenic | 2 | 2015 | 623 | 0.150 |
Why?
|
| Leukemia, Myeloid, Acute | 4 | 2016 | 3523 | 0.150 |
Why?
|
| Hydroxamic Acids | 1 | 2020 | 495 | 0.150 |
Why?
|
| Ribosomal Protein S6 Kinases, 70-kDa | 1 | 2017 | 104 | 0.150 |
Why?
|
| Protein Structure, Tertiary | 8 | 2020 | 3846 | 0.140 |
Why?
|
| Mice, Nude | 9 | 2018 | 3689 | 0.140 |
Why?
|
| Drug Synergism | 6 | 2018 | 1791 | 0.140 |
Why?
|
| Maleates | 1 | 2015 | 17 | 0.140 |
Why?
|
| Drug Delivery Systems | 6 | 2022 | 2218 | 0.140 |
Why?
|
| I-kappa B Kinase | 2 | 2007 | 252 | 0.130 |
Why?
|
| Nitrophenols | 1 | 2016 | 172 | 0.130 |
Why?
|
| Angiogenesis Inhibitors | 2 | 2005 | 2038 | 0.130 |
Why?
|
| Polystyrenes | 1 | 2015 | 112 | 0.130 |
Why?
|
| Drug Design | 1 | 2020 | 1078 | 0.120 |
Why?
|
| Enzyme Activation | 9 | 2013 | 3701 | 0.120 |
Why?
|
| Cell Proliferation | 9 | 2020 | 10480 | 0.120 |
Why?
|
| Mice | 24 | 2023 | 81178 | 0.120 |
Why?
|
| Xenograft Model Antitumor Assays | 6 | 2018 | 3557 | 0.120 |
Why?
|
| Amino Acid Sequence | 12 | 2015 | 13817 | 0.110 |
Why?
|
| Cell Nucleus | 7 | 2011 | 2969 | 0.110 |
Why?
|
| Ferric Compounds | 1 | 2014 | 374 | 0.110 |
Why?
|
| Gene Expression Regulation, Leukemic | 1 | 2016 | 651 | 0.110 |
Why?
|
| Poloxamer | 2 | 2022 | 57 | 0.110 |
Why?
|
| Neoplastic Stem Cells | 1 | 2020 | 1376 | 0.100 |
Why?
|
| Cytotoxins | 1 | 2012 | 153 | 0.100 |
Why?
|
| Biphenyl Compounds | 1 | 2016 | 914 | 0.100 |
Why?
|
| Transcriptional Activation | 3 | 2009 | 1782 | 0.100 |
Why?
|
| Protein Binding | 11 | 2015 | 9392 | 0.100 |
Why?
|
| U937 Cells | 4 | 2009 | 268 | 0.100 |
Why?
|
| Neovascularization, Pathologic | 1 | 2002 | 2636 | 0.100 |
Why?
|
| Aniline Compounds | 1 | 2016 | 986 | 0.100 |
Why?
|
| Tumor Necrosis Factor-alpha | 5 | 2017 | 4419 | 0.100 |
Why?
|
| Oxidative Stress | 4 | 2016 | 3085 | 0.100 |
Why?
|
| Animals | 29 | 2023 | 168788 | 0.100 |
Why?
|
| Janus Kinase 1 | 1 | 2011 | 104 | 0.100 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2011 | 323 | 0.100 |
Why?
|
| Immunoconjugates | 1 | 2018 | 901 | 0.100 |
Why?
|
| Polyesters | 2 | 2023 | 363 | 0.090 |
Why?
|
| I-kappa B Proteins | 2 | 2009 | 225 | 0.090 |
Why?
|
| Magnetite Nanoparticles | 1 | 2012 | 321 | 0.090 |
Why?
|
| Oxidation-Reduction | 5 | 2017 | 2187 | 0.090 |
Why?
|
| Disulfides | 1 | 2011 | 457 | 0.090 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 2 | 2003 | 452 | 0.090 |
Why?
|
| Colorectal Neoplasms | 3 | 2020 | 6773 | 0.090 |
Why?
|
| Antigens, Neoplasm | 4 | 2006 | 1987 | 0.090 |
Why?
|
| Protein Multimerization | 4 | 2017 | 971 | 0.090 |
Why?
|
| Staurosporine | 1 | 2010 | 251 | 0.090 |
Why?
|
| Molecular Sequence Data | 9 | 2015 | 18116 | 0.090 |
Why?
|
| Inhibitory Concentration 50 | 3 | 2015 | 459 | 0.080 |
Why?
|
| Doxorubicin | 3 | 2023 | 2220 | 0.080 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 3 | 2017 | 2916 | 0.080 |
Why?
|
| ADP-Ribosylation Factor 1 | 1 | 2008 | 43 | 0.080 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 2 | 2003 | 647 | 0.080 |
Why?
|
| Receptors, Death Domain | 1 | 2008 | 32 | 0.080 |
Why?
|
| Hep G2 Cells | 3 | 2014 | 392 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 2 | 2008 | 380 | 0.080 |
Why?
|
| Phosphorylation | 10 | 2011 | 8437 | 0.080 |
Why?
|
| Cell Cycle | 3 | 2011 | 2967 | 0.080 |
Why?
|
| Multiple Myeloma | 4 | 2010 | 5180 | 0.080 |
Why?
|
| Fusion Proteins, bcr-abl | 1 | 2010 | 434 | 0.080 |
Why?
|
| Caspase 8 | 1 | 2008 | 195 | 0.080 |
Why?
|
| HCT116 Cells | 4 | 2011 | 408 | 0.080 |
Why?
|
| Immunoblotting | 5 | 2011 | 1682 | 0.080 |
Why?
|
| Drug Resistance, Neoplasm | 3 | 2016 | 5169 | 0.080 |
Why?
|
| Genetic Vectors | 1 | 2017 | 3420 | 0.070 |
Why?
|
| Biocompatible Materials | 1 | 2015 | 1736 | 0.070 |
Why?
|
| Mitochondria | 6 | 2009 | 3520 | 0.070 |
Why?
|
| STAT3 Transcription Factor | 1 | 2011 | 874 | 0.070 |
Why?
|
| Breast Neoplasms | 6 | 2018 | 20817 | 0.070 |
Why?
|
| Sulfonamides | 1 | 2016 | 1940 | 0.070 |
Why?
|
| Antimitotic Agents | 1 | 2006 | 30 | 0.070 |
Why?
|
| Tumor Cells, Cultured | 7 | 2013 | 6313 | 0.070 |
Why?
|
| Cysteine | 2 | 2011 | 874 | 0.070 |
Why?
|
| RNA, Small Interfering | 6 | 2016 | 3505 | 0.070 |
Why?
|
| Mitogen-Activated Protein Kinases | 2 | 2002 | 1284 | 0.070 |
Why?
|
| Cytoplasm | 5 | 2011 | 1539 | 0.070 |
Why?
|
| Neuregulin-1 | 2 | 2004 | 142 | 0.070 |
Why?
|
| Molecular Targeted Therapy | 3 | 2015 | 2727 | 0.070 |
Why?
|
| Galectin 3 | 1 | 2007 | 227 | 0.070 |
Why?
|
| Receptors, Androgen | 1 | 2012 | 1057 | 0.070 |
Why?
|
| beta Catenin | 3 | 2005 | 1059 | 0.070 |
Why?
|
| HEK293 Cells | 4 | 2020 | 4201 | 0.070 |
Why?
|
| Folic Acid | 1 | 2012 | 1300 | 0.070 |
Why?
|
| Mucins | 2 | 2006 | 564 | 0.070 |
Why?
|
| Tissue Distribution | 2 | 2023 | 2335 | 0.070 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2008 | 2948 | 0.070 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2010 | 689 | 0.070 |
Why?
|
| Gene Expression Regulation, Neoplastic | 6 | 2020 | 8426 | 0.060 |
Why?
|
| Amino Acid Motifs | 3 | 2015 | 936 | 0.060 |
Why?
|
| Tumor Microenvironment | 1 | 2017 | 3584 | 0.060 |
Why?
|
| Humans | 53 | 2021 | 744220 | 0.060 |
Why?
|
| Protein Subunits | 4 | 2011 | 960 | 0.060 |
Why?
|
| Androgens | 1 | 2012 | 1279 | 0.060 |
Why?
|
| DNA Topoisomerases, Type I | 1 | 2004 | 102 | 0.060 |
Why?
|
| Signal Transduction | 8 | 2017 | 23404 | 0.060 |
Why?
|
| Drug Stability | 2 | 2015 | 291 | 0.060 |
Why?
|
| CA-125 Antigen | 1 | 2006 | 286 | 0.060 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2005 | 430 | 0.060 |
Why?
|
| Cytoskeletal Proteins | 3 | 2003 | 1364 | 0.060 |
Why?
|
| Leukemia | 1 | 2011 | 1508 | 0.060 |
Why?
|
| Drug Carriers | 2 | 2020 | 693 | 0.060 |
Why?
|
| Caspase 3 | 4 | 2010 | 759 | 0.060 |
Why?
|
| Cell Nucleolus | 1 | 2003 | 166 | 0.050 |
Why?
|
| Apoptosis Regulatory Proteins | 4 | 2017 | 1157 | 0.050 |
Why?
|
| Epirubicin | 1 | 2022 | 80 | 0.050 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2006 | 627 | 0.050 |
Why?
|
| Cell Death | 3 | 2015 | 1708 | 0.050 |
Why?
|
| Drug Screening Assays, Antitumor | 3 | 2014 | 731 | 0.050 |
Why?
|
| Protein Biosynthesis | 2 | 2017 | 2126 | 0.050 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2012 | 3760 | 0.050 |
Why?
|
| Protein Synthesis Inhibitors | 1 | 2002 | 192 | 0.050 |
Why?
|
| Taxoids | 1 | 2005 | 665 | 0.050 |
Why?
|
| NF-kappa B | 2 | 2010 | 2501 | 0.050 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2011 | 2942 | 0.050 |
Why?
|
| Collagen Type IV | 1 | 2002 | 140 | 0.050 |
Why?
|
| Prostatic Neoplasms | 3 | 2012 | 11074 | 0.050 |
Why?
|
| Camptothecin | 1 | 2004 | 576 | 0.050 |
Why?
|
| Autophagy | 1 | 2009 | 1300 | 0.050 |
Why?
|
| Antibodies, Monoclonal | 1 | 2018 | 9275 | 0.050 |
Why?
|
| Mitosis | 1 | 2006 | 1208 | 0.050 |
Why?
|
| Carcinoma | 2 | 2018 | 2375 | 0.050 |
Why?
|
| Growth Inhibitors | 1 | 2002 | 385 | 0.050 |
Why?
|
| Necrosis | 3 | 2011 | 1643 | 0.050 |
Why?
|
| Mitochondrial Proteins | 2 | 2004 | 996 | 0.050 |
Why?
|
| Cytarabine | 1 | 2002 | 692 | 0.050 |
Why?
|
| Luciferases | 3 | 2011 | 733 | 0.040 |
Why?
|
| src-Family Kinases | 1 | 2002 | 551 | 0.040 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 2 | 2011 | 5221 | 0.040 |
Why?
|
| Radiation, Ionizing | 1 | 2000 | 258 | 0.040 |
Why?
|
| DNA-Binding Proteins | 1 | 2017 | 9647 | 0.040 |
Why?
|
| Endothelium, Vascular | 2 | 2002 | 4455 | 0.040 |
Why?
|
| Cell Growth Processes | 2 | 2010 | 400 | 0.040 |
Why?
|
| Promoter Regions, Genetic | 4 | 2016 | 5867 | 0.040 |
Why?
|
| Contrast Media | 1 | 2012 | 5300 | 0.040 |
Why?
|
| Immunoprecipitation | 2 | 2011 | 905 | 0.040 |
Why?
|
| Tumor Burden | 2 | 2015 | 1914 | 0.040 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2022 | 692 | 0.040 |
Why?
|
| Antimetabolites, Antineoplastic | 1 | 2002 | 640 | 0.040 |
Why?
|
| Transcription Factors | 2 | 2017 | 12207 | 0.040 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2012 | 4752 | 0.040 |
Why?
|
| Rats | 4 | 2020 | 24273 | 0.040 |
Why?
|
| Down-Regulation | 3 | 2012 | 3001 | 0.040 |
Why?
|
| Cisplatin | 2 | 2004 | 1642 | 0.040 |
Why?
|
| Antigens | 1 | 2004 | 1466 | 0.040 |
Why?
|
| Oncogenes | 1 | 2003 | 1265 | 0.040 |
Why?
|
| Dexamethasone | 1 | 2004 | 1948 | 0.040 |
Why?
|
| Autoantigens | 1 | 2002 | 892 | 0.040 |
Why?
|
| Protein Transport | 2 | 2015 | 1989 | 0.040 |
Why?
|
| Evolution, Molecular | 1 | 2006 | 1939 | 0.040 |
Why?
|
| Fluorouracil | 1 | 2002 | 1616 | 0.040 |
Why?
|
| Glucose | 1 | 2009 | 4396 | 0.040 |
Why?
|
| Mice, Mutant Strains | 1 | 2000 | 1866 | 0.040 |
Why?
|
| HeLa Cells | 3 | 2009 | 3129 | 0.040 |
Why?
|
| Up-Regulation | 4 | 2007 | 4217 | 0.040 |
Why?
|
| Proto-Oncogene Proteins | 3 | 2003 | 4553 | 0.040 |
Why?
|
| Blotting, Western | 3 | 2011 | 5180 | 0.030 |
Why?
|
| Genes, Tumor Suppressor | 2 | 2016 | 1097 | 0.030 |
Why?
|
| NF-kappa B p50 Subunit | 1 | 2016 | 107 | 0.030 |
Why?
|
| Erythrocyte Aggregation | 1 | 2015 | 36 | 0.030 |
Why?
|
| Cyclophosphamide | 1 | 2002 | 2236 | 0.030 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2017 | 297 | 0.030 |
Why?
|
| Glycoproteins | 1 | 2004 | 2263 | 0.030 |
Why?
|
| Gene Silencing | 2 | 2016 | 1538 | 0.030 |
Why?
|
| MicroRNAs | 2 | 2012 | 3747 | 0.030 |
Why?
|
| Cell Line | 5 | 2011 | 15999 | 0.030 |
Why?
|
| Carrier Proteins | 3 | 2004 | 5021 | 0.030 |
Why?
|
| bcl-X Protein | 2 | 2009 | 411 | 0.030 |
Why?
|
| Albumins | 1 | 2018 | 569 | 0.030 |
Why?
|
| Luminescent Proteins | 2 | 2011 | 853 | 0.030 |
Why?
|
| Transfection | 3 | 2011 | 5892 | 0.030 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2017 | 431 | 0.030 |
Why?
|
| Blood Cell Count | 1 | 2015 | 402 | 0.030 |
Why?
|
| Caspase 9 | 2 | 2005 | 188 | 0.030 |
Why?
|
| src Homology Domains | 2 | 2006 | 364 | 0.030 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2020 | 1372 | 0.030 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2015 | 643 | 0.030 |
Why?
|
| Azacitidine | 1 | 2016 | 347 | 0.030 |
Why?
|
| Protein Stability | 1 | 2016 | 557 | 0.030 |
Why?
|
| Piperazines | 3 | 2016 | 2491 | 0.030 |
Why?
|
| Glutathione | 1 | 2017 | 588 | 0.030 |
Why?
|
| Adenocarcinoma | 1 | 2012 | 6352 | 0.030 |
Why?
|
| Antigens, CD34 | 1 | 2016 | 657 | 0.030 |
Why?
|
| Propylene Glycols | 1 | 2014 | 92 | 0.030 |
Why?
|
| Aorta | 1 | 2002 | 2061 | 0.030 |
Why?
|
| Pyrimidines | 2 | 2005 | 2940 | 0.030 |
Why?
|
| Drug Compounding | 1 | 2015 | 243 | 0.030 |
Why?
|
| Transcription, Genetic | 2 | 2008 | 7723 | 0.030 |
Why?
|
| Cytochromes c | 2 | 2004 | 180 | 0.030 |
Why?
|
| Hemolysis | 1 | 2015 | 420 | 0.030 |
Why?
|
| Binding Sites | 3 | 2011 | 6116 | 0.030 |
Why?
|
| Maximum Tolerated Dose | 1 | 2015 | 892 | 0.030 |
Why?
|
| Lactates | 1 | 2014 | 432 | 0.030 |
Why?
|
| Folate Receptors, GPI-Anchored | 1 | 2012 | 23 | 0.030 |
Why?
|
| RNA, Messenger | 4 | 2012 | 13036 | 0.030 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2020 | 1221 | 0.030 |
Why?
|
| Reducing Agents | 1 | 2011 | 12 | 0.030 |
Why?
|
| Female | 12 | 2020 | 380197 | 0.030 |
Why?
|
| Cadherins | 1 | 2016 | 907 | 0.020 |
Why?
|
| Active Transport, Cell Nucleus | 2 | 2003 | 443 | 0.020 |
Why?
|
| Area Under Curve | 1 | 2015 | 1655 | 0.020 |
Why?
|
| Microscopy, Confocal | 2 | 2011 | 1971 | 0.020 |
Why?
|
| Histocytochemistry | 1 | 2012 | 719 | 0.020 |
Why?
|
| Cells, Cultured | 3 | 2004 | 19227 | 0.020 |
Why?
|
| Endocytosis | 1 | 2015 | 985 | 0.020 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 1 | 2012 | 407 | 0.020 |
Why?
|
| Tandem Repeat Sequences | 1 | 2011 | 185 | 0.020 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2015 | 2557 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2002 | 8302 | 0.020 |
Why?
|
| Delayed-Action Preparations | 1 | 2014 | 964 | 0.020 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2012 | 713 | 0.020 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2012 | 474 | 0.020 |
Why?
|
| Dimerization | 1 | 2011 | 893 | 0.020 |
Why?
|
| Neoplasm Transplantation | 1 | 2014 | 2085 | 0.020 |
Why?
|
| Myelopoiesis | 1 | 2010 | 133 | 0.020 |
Why?
|
| Particle Size | 1 | 2014 | 1642 | 0.020 |
Why?
|
| Acetylcysteine | 1 | 2011 | 272 | 0.020 |
Why?
|
| Cell Movement | 1 | 2002 | 5216 | 0.020 |
Why?
|
| Membrane Potentials | 2 | 2003 | 1137 | 0.020 |
Why?
|
| Ubiquitin-Activating Enzymes | 1 | 2009 | 83 | 0.020 |
Why?
|
| Membrane Proteins | 1 | 2006 | 7879 | 0.020 |
Why?
|
| K562 Cells | 1 | 2010 | 634 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2011 | 3772 | 0.020 |
Why?
|
| Biopolymers | 1 | 2009 | 189 | 0.020 |
Why?
|
| Polyethylene Glycols | 1 | 2014 | 1181 | 0.020 |
Why?
|
| Colonic Neoplasms | 1 | 2020 | 2538 | 0.020 |
Why?
|
| TNF Receptor-Associated Factor 2 | 1 | 2007 | 59 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2018 | 5458 | 0.020 |
Why?
|
| Benzamides | 2 | 2005 | 1378 | 0.020 |
Why?
|
| Lung Neoplasms | 2 | 2018 | 13096 | 0.020 |
Why?
|
| Asparagine | 1 | 2007 | 122 | 0.020 |
Why?
|
| Nuclear Proteins | 1 | 2002 | 5853 | 0.020 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2005 | 11493 | 0.020 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2010 | 893 | 0.020 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2012 | 713 | 0.020 |
Why?
|
| Gene Expression Regulation | 3 | 2017 | 12075 | 0.020 |
Why?
|
| Receptor-Interacting Protein Serine-Threonine Kinases | 1 | 2007 | 143 | 0.020 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type I | 1 | 2007 | 264 | 0.020 |
Why?
|
| Cell Adhesion | 2 | 2003 | 3144 | 0.020 |
Why?
|
| Procollagen-Proline Dioxygenase | 1 | 2006 | 86 | 0.020 |
Why?
|
| Mutation | 5 | 2011 | 29784 | 0.020 |
Why?
|
| Mucin-4 | 1 | 2006 | 37 | 0.020 |
Why?
|
| MAP Kinase Kinase Kinases | 1 | 2007 | 261 | 0.020 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2009 | 608 | 0.020 |
Why?
|
| Subcellular Fractions | 1 | 2006 | 547 | 0.020 |
Why?
|
| Cricetulus | 1 | 2007 | 817 | 0.020 |
Why?
|
| Hydrogen Peroxide | 1 | 2009 | 731 | 0.020 |
Why?
|
| Antigens, CD | 1 | 2016 | 4026 | 0.020 |
Why?
|
| 14-3-3 Proteins | 1 | 2006 | 214 | 0.020 |
Why?
|
| RNA Stability | 1 | 2007 | 322 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2015 | 6535 | 0.020 |
Why?
|
| Body Weight | 1 | 2015 | 4666 | 0.020 |
Why?
|
| CHO Cells | 1 | 2007 | 1407 | 0.020 |
Why?
|
| Topoisomerase I Inhibitors | 1 | 2004 | 65 | 0.020 |
Why?
|
| Multiprotein Complexes | 1 | 2011 | 1119 | 0.020 |
Why?
|
| Flow Cytometry | 2 | 2006 | 5974 | 0.020 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2007 | 2915 | 0.020 |
Why?
|
| Glycosylation | 1 | 2007 | 1126 | 0.020 |
Why?
|
| Phantoms, Imaging | 1 | 2012 | 2480 | 0.010 |
Why?
|
| Carcinogenicity Tests | 1 | 2003 | 41 | 0.010 |
Why?
|
| Computational Biology | 1 | 2016 | 3523 | 0.010 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2012 | 1990 | 0.010 |
Why?
|
| Adenine | 1 | 2009 | 936 | 0.010 |
Why?
|
| Enzyme Inhibitors | 2 | 2006 | 3800 | 0.010 |
Why?
|
| Neoplasm Invasiveness | 1 | 2012 | 3614 | 0.010 |
Why?
|
| Tumor Stem Cell Assay | 1 | 2003 | 118 | 0.010 |
Why?
|
| gamma Catenin | 1 | 2003 | 44 | 0.010 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2009 | 1086 | 0.010 |
Why?
|
| Cricetinae | 1 | 2007 | 2472 | 0.010 |
Why?
|
| Trans-Activators | 2 | 2003 | 2924 | 0.010 |
Why?
|
| Desmoplakins | 1 | 2003 | 62 | 0.010 |
Why?
|
| Tetrazolium Salts | 1 | 2003 | 96 | 0.010 |
Why?
|
| Cell Differentiation | 2 | 2011 | 11478 | 0.010 |
Why?
|
| Anthracenes | 1 | 2003 | 84 | 0.010 |
Why?
|
| Cytochrome c Group | 1 | 2003 | 128 | 0.010 |
Why?
|
| Fibroblasts | 2 | 2004 | 4156 | 0.010 |
Why?
|
| TNF-Related Apoptosis-Inducing Ligand | 1 | 2004 | 197 | 0.010 |
Why?
|
| DNA | 1 | 2017 | 7303 | 0.010 |
Why?
|
| Adenosine Triphosphate | 1 | 2009 | 2025 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinase 8 | 1 | 2002 | 77 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2006 | 10949 | 0.010 |
Why?
|
| Male | 6 | 2017 | 350027 | 0.010 |
Why?
|
| DNA Methylation | 1 | 2016 | 4289 | 0.010 |
Why?
|
| Receptors, Vitronectin | 1 | 2002 | 52 | 0.010 |
Why?
|
| Peptide Initiation Factors | 1 | 2002 | 56 | 0.010 |
Why?
|
| Cytokines | 1 | 2017 | 7326 | 0.010 |
Why?
|
| RNA Interference | 1 | 2011 | 2890 | 0.010 |
Why?
|
| Tyrosine | 1 | 2006 | 1461 | 0.010 |
Why?
|
| Transplantation, Heterologous | 1 | 2010 | 2382 | 0.010 |
Why?
|
| Precipitin Tests | 1 | 2002 | 829 | 0.010 |
Why?
|
| RNA Caps | 1 | 2002 | 74 | 0.010 |
Why?
|
| Eukaryotic Initiation Factors | 1 | 2002 | 92 | 0.010 |
Why?
|
| Focal Adhesion Kinase 1 | 1 | 2002 | 120 | 0.010 |
Why?
|
| Cyclin D1 | 1 | 2003 | 462 | 0.010 |
Why?
|
| Cell Transplantation | 1 | 2003 | 477 | 0.010 |
Why?
|
| Focal Adhesion Protein-Tyrosine Kinases | 1 | 2002 | 182 | 0.010 |
Why?
|
| Eukaryotic Initiation Factor-4E | 1 | 2002 | 107 | 0.010 |
Why?
|
| Interleukin-6 | 1 | 2011 | 3201 | 0.010 |
Why?
|
| Glutathione Transferase | 1 | 2002 | 595 | 0.010 |
Why?
|
| Coloring Agents | 1 | 2003 | 566 | 0.010 |
Why?
|
| Epidermal Growth Factor | 1 | 2003 | 709 | 0.010 |
Why?
|
| Microtubules | 1 | 2006 | 1091 | 0.010 |
Why?
|
| Genes, Dominant | 1 | 2003 | 880 | 0.010 |
Why?
|
| Clone Cells | 1 | 2003 | 1692 | 0.010 |
Why?
|
| Homeostasis | 1 | 2011 | 3339 | 0.010 |
Why?
|
| Neoplasms, Experimental | 1 | 2005 | 1275 | 0.010 |
Why?
|
| Cytosol | 1 | 2003 | 901 | 0.010 |
Why?
|
| Wnt Proteins | 1 | 2003 | 721 | 0.010 |
Why?
|
| Genes, Reporter | 1 | 2003 | 1547 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 2003 | 2050 | 0.010 |
Why?
|
| Serine | 1 | 2003 | 828 | 0.010 |
Why?
|
| Cell Division | 1 | 2006 | 4567 | 0.010 |
Why?
|
| Phylogeny | 1 | 2006 | 2803 | 0.010 |
Why?
|
| Drug Resistance | 1 | 2004 | 1608 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 2004 | 4321 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2017 | 18027 | 0.010 |
Why?
|
| Drug Interactions | 1 | 2002 | 1458 | 0.010 |
Why?
|
| Ubiquitin | 1 | 2002 | 852 | 0.010 |
Why?
|
| Green Fluorescent Proteins | 1 | 2003 | 2088 | 0.010 |
Why?
|
| Plasmids | 1 | 2002 | 2307 | 0.010 |
Why?
|
| Epithelial Cells | 1 | 2009 | 3690 | 0.010 |
Why?
|
| Models, Biological | 2 | 2004 | 9582 | 0.010 |
Why?
|
| Inflammation | 1 | 2017 | 10634 | 0.010 |
Why?
|
| Base Sequence | 1 | 2008 | 12801 | 0.010 |
Why?
|
| Hematologic Neoplasms | 1 | 2008 | 1831 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2006 | 6612 | 0.010 |
Why?
|
| Cattle | 1 | 2002 | 3922 | 0.010 |
Why?
|
| Thiazoles | 1 | 2003 | 1484 | 0.010 |
Why?
|
| Oxygen | 1 | 2006 | 4187 | 0.010 |
Why?
|
| Protein Kinases | 1 | 2002 | 1639 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 1 | 2006 | 4803 | 0.010 |
Why?
|
| Cell Membrane | 1 | 2003 | 3748 | 0.010 |
Why?
|
| Receptor, erbB-2 | 1 | 2003 | 2416 | 0.010 |
Why?
|
| Phenotype | 1 | 2011 | 16365 | 0.010 |
Why?
|
| Disease Progression | 1 | 2009 | 13280 | 0.010 |
Why?
|
| Phosphoproteins | 1 | 2002 | 2440 | 0.010 |
Why?
|
| Membrane Glycoproteins | 1 | 2004 | 3769 | 0.010 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2002 | 2108 | 0.010 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2002 | 2455 | 0.010 |
Why?
|
| Neoplasm Proteins | 1 | 2003 | 3703 | 0.010 |
Why?
|
| Cell Cycle Proteins | 1 | 2002 | 3461 | 0.010 |
Why?
|
| Peptide Fragments | 1 | 2002 | 5096 | 0.010 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2002 | 5529 | 0.000 |
Why?
|
| Aged, 80 and over | 1 | 2010 | 57768 | 0.000 |
Why?
|
| Time Factors | 1 | 2003 | 40063 | 0.000 |
Why?
|
| Aged | 1 | 2010 | 163253 | 0.000 |
Why?
|